Renovaro Biosciences Statistics
Total Valuation
RENB has a market cap or net worth of $199.13 million. The enterprise value is $207.39 million.
Market Cap | 199.13M |
Enterprise Value | 207.39M |
Important Dates
The last earnings date was Wednesday, May 15, 2024, after market close.
Earnings Date | May 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RENB has 147.51 million shares outstanding. The number of shares has increased by 92.02% in one year.
Shares Outstanding | 147.51M |
Shares Change (YoY) | +92.02% |
Shares Change (QoQ) | +63.21% |
Owned by Insiders (%) | 25.52% |
Owned by Institutions (%) | 4.93% |
Float | 81.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06, with a Debt / Equity ratio of 0.05.
Current Ratio | 0.06 |
Quick Ratio | n/a |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -58.26 |
Financial Efficiency
Return on equity (ROE) is -70.60% and return on invested capital (ROIC) is -30.07%.
Return on Equity (ROE) | -70.60% |
Return on Assets (ROA) | -55.90% |
Return on Capital (ROIC) | -30.07% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.49M |
Employee Count | 12 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +121.78% in the last 52 weeks. The beta is 0.59, so RENB's price volatility has been lower than the market average.
Beta (5Y) | 0.59 |
52-Week Price Change | +121.78% |
50-Day Moving Average | 1.39 |
200-Day Moving Average | 2.72 |
Relative Strength Index (RSI) | 40.71 |
Average Volume (20 Days) | 883,060 |
Short Selling Information
The latest short interest is 2.56 million, so 1.74% of the outstanding shares have been sold short.
Short Interest | 2.56M |
Short Previous Month | 1.58M |
Short % of Shares Out | 1.74% |
Short % of Float | 3.17% |
Short Ratio (days to cover) | 1.81 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -53.28M |
Pretax Income | -53.93M |
Net Income | -53.93M |
EBITDA | -52.90M |
EBIT | -53.02M |
Earnings Per Share (EPS) | -$0.78 |
Balance Sheet
The company has $312,697 in cash and $8.57 million in debt, giving a net cash position of -$8.26 million or -$0.06 per share.
Cash & Cash Equivalents | 312,697 |
Total Debt | 8.57M |
Net Cash | -8.26M |
Net Cash Per Share | -$0.06 |
Equity (Book Value) | 168.60M |
Book Value Per Share | 1.14 |
Working Capital | -19.65M |
Cash Flow
In the last 12 months, operating cash flow was -$10.82 million and capital expenditures -$53,019, giving a free cash flow of -$10.87 million.
Operating Cash Flow | -10.82M |
Capital Expenditures | -53,019 |
Free Cash Flow | -10.87M |
FCF Per Share | -$0.10 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RENB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -92.02% |
Shareholder Yield | -92.02% |
Earnings Yield | -27.08% |
FCF Yield | -5.46% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |